Key Points
- Greater Manchester has been identified as an area where young women are most likely to be diagnosed late for breast cancer, based on data from CoppaFeel! covered by the Manchester Evening News.
- According to CoppaFeel!, 23.5% of breast cancer diagnoses among women under 50 years old in Greater Manchester are made at stage three and four.
- The charity claims that this figure compares poorly with 7% in Cornwall and the Isles of Scilly, which means that women in Greater Manchester are nearly four times more likely to receive a diagnosis at a late stage of the disease.
- Birmingham and Solihull has the highest rate in the country, with 30%, while Greater Manchester is one of 19 regions where over 20% of under-50 cases of breast cancer are diagnosed at a later stage.
- According to CoppaFeel!, young women under 50 years old are almost twice as likely to receive a late-stage diagnosis compared to women over 60 years old.
- The charity is urging to establish a pilot program of risk-based screening of women aged 18-49 based on a seven-minute assessment, including family history, breast density and polygenic risk with a saliva test.
Manchester (Manchester Mirror) October 30, 2026 — Greater Manchester has been named among the areas of the UK where women under 50 are most likely to be diagnosed with breast cancer at a late stage, according to new figures compiled by the breast cancer awareness charity CoppaFeel!.
As reported by the Manchester Evening News, the charity’s data shows that 23.5% of breast cancer cases in women under 50 in Greater Manchester are diagnosed at stage three or four. These are considered late-stage diagnoses, when the disease has progressed further and treatment can become more complex.
The figure is nearly four times higher than the 7% recorded in Cornwall and the Isles of Scilly, the area with the lowest reported rate in the charity’s analysis. CoppaFeel! says the difference points to “systemic gaps in early detection and awareness for younger people”.
Greater Manchester is not the highest-ranked area nationally. As reported by The Scottish Sun and The Sun, Birmingham and Solihull tops the list, with 30% of women under 50 diagnosed at stage three or four. Greater Manchester is among 19 areas where more than 20% of under-50 breast cancer patients receive a late-stage diagnosis.
What Do the CoppaFeel! Figures Show?
CoppaFeel!, which describes itself as the UK’s only breast cancer awareness charity for young people, says the data shows that age and postcode can both affect how early breast cancer is detected.
The charity says that, across the UK, women under 50 are almost twice as likely to be diagnosed with late-stage breast cancer as women in their 60s. Its policy report also states that under-25s are more than twice as likely to be diagnosed with late-stage disease.
Late diagnosis matters because CoppaFeel! says people diagnosed at stage one or two are more likely to survive for five years or more. The charity says younger people can also be more likely to have more aggressive forms of breast cancer, later recurrences and lower long-term survival.
In Greater Manchester specifically, the Manchester Evening News reports that the five-year breast cancer survival rate across all age groups is 86.1%, based on data from the Greater Manchester Integrated Care Board. It says this is among the lowest rates in the UK and compares with 90.6% in Suffolk and North East Essex.
The same report states that women aged 25 to 49 in Greater Manchester are 19% more likely to be diagnosed with breast cancer than women of the same age in North East London.
What Is CoppaFeel! Calling For?
CoppaFeel! is urging the government to introduce risk-based breast cancer screening for younger women. At present, the NHS invites women for routine breast screening from age 50 to 71.
The charity wants a pilot programme for women aged 18 to 49. It proposes a seven-minute risk assessment that would consider family history, breast density and polygenic risk, with a saliva test used to help identify women who may need earlier or more frequent screening.
As reported by Bauer Media’s HelloRayo, CoppaFeel! says such an approach would replace a system that relies on age alone and identify people who may benefit from earlier monitoring.
The charity is also calling for breast health to be discussed during routine NHS appointments, including cervical screening, HPV vaccination and NHS Health Checks. It says this could help younger women recognise changes and seek medical advice sooner.
What Has CoppaFeel! Said?
Sophie Dopierala-Bull, director of services and engagement at CoppaFeel!, described the number of young women receiving late-stage diagnoses as “unacceptably high”.
As reported by the Manchester Evening News, she said breast cancer is still often perceived as a condition affecting older people, and that some younger women report being dismissed as “too young” when they first seek help. She said every late diagnosis represents a lost opportunity to treat the disease before it becomes harder to manage.
CoppaFeel! was founded by twin sisters Kris Hallenga and Maren Hallenga after Kris was diagnosed with breast cancer at the age of 23. The charity says it wants earlier awareness, better risk assessment and improved support for young people affected by breast cancer.
How Is Greater Manchester Responding?
Dr Sarah Taylor, medical director for primary care at the Greater Manchester Cancer Alliance, said work is under way to improve awareness among younger women. As reported by the Manchester Evening News, she said early cancer diagnosis improves survival rates and that the alliance recognises the number of women under 50 being diagnosed in the region.
Dr Taylor said the alliance has promoted earlier detection through the “Look and Feel Every Month” campaign, which encourages women below screening age to understand what is normal for their bodies and to seek help promptly if they notice changes.
The Greater Manchester Cancer Alliance’s “Get Cancer Clever” initiative focuses on common cancer symptoms, addresses myths and encourages people to contact their GP when they notice possible warning signs. The alliance says its work aims to support earlier diagnosis, better treatment and improved quality of life for people living with and beyond cancer.
The alliance has also launched a workplace-focused element of Get Cancer Clever with The Growth Company. According to a Greater Manchester Cancer Alliance campaign update, the initiative invites employers to receive NHS-approved information about cancer symptoms and early diagnosis, and to support employees affected by cancer.
What Has the Government Said?
A Department of Health and Social Care spokesperson said all women should receive equivalent care and screening opportunities regardless of where they live or their ethnicity. As reported by the Manchester Evening News, the department said it is committed to addressing disparities.
The spokesperson said more women are attending their first breast screening appointment than at any point in the past decade, but acknowledged that more work remains. The department said its National Cancer Plan is providing funding for targeted local action to tackle inequalities, improve screening participation and enable earlier cancer diagnosis.
The government has also announced a three-year partnership with Breast Cancer Now. According to the Manchester Evening News, the collaboration is intended to help women recognise breast cancer signs and symptoms and improve support after treatment.
Background of the Development
Breast cancer screening in England is currently offered to women and people registered with their GP as female between the ages of 50 and 71, with invitations sent by post or text. Greater Manchester Cancer Alliance information confirms that this is the age range for its breast screening programme.
CoppaFeel! argues that this age-based approach does not account for individual risk among younger women. Its proposed model would use family history, breast density and genetic risk indicators to identify people who may need earlier assessment or monitoring.
The charity’s findings come amid wider concern about variation in cancer outcomes across England. Its data places Greater Manchester alongside areas including London, Lincolnshire, Coventry and Warwickshire, Norfolk, Cumbria, Kent, Yorkshire, Gloucestershire and Northamptonshire among the regions with late-diagnosis rates above 20% for women under 50.
Greater Manchester Cancer Alliance has previously reported that its Breast Cancer Risk Prediction Team, established in 2019, identified 140 women at increased breast cancer risk who would not have been identified through standard care. The alliance says those women were able to benefit from earlier screening and preventive measures.
Prediction: How Could This Affect Young Women in Greater Manchester?
For young women in Greater Manchester, the development could increase attention on breast awareness, symptom recognition and the importance of contacting a GP promptly about changes. The Greater Manchester Cancer Alliance’s existing campaigns encourage monthly self-checks and earlier presentation, which may become more visible if the late-diagnosis data prompts further local outreach.
If CoppaFeel!’s call for risk-based screening is adopted or piloted, women aged 18 to 49 with a family history, higher breast density or other risk indicators could in future be assessed for earlier or more frequent monitoring. That could change how some younger women access breast health services, although any new programme would depend on government decisions, NHS capacity and clinical evidence.
For local health services, the figures may increase pressure to demonstrate progress on earlier diagnosis, particularly in communities where late-stage diagnoses are more common. Greater Manchester Cancer Alliance says its Get Cancer Clever work includes community outreach, support for GP practices and workplace programmes, which could expand if local partners respond to the findings.
For employers, the alliance’s workplace initiative may become more relevant, as it provides resources to help staff discuss cancer concerns and access trusted information. For families and carers, greater awareness could mean more conversations about symptoms, screening eligibility and support available during diagnosis and treatment.
